Despite spending more than $1 billion every year on drugs, insecticide-treated nets, diagnostics, and public health campaigns, malaria remains deeply entrenched in Nigeria, a paradox experts at the Nigerian Institute of Medical Research (NIMR) attribute not to failed science but to biological resist
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Royal Ibeh
Royal Ibeh is a senior journalist with years of experience reporting on Nigeria’s technology and health sectors. She currently covers the Technology and Health beats for BusinessDay newspaper, where she writes in-depth stories on digital innovation, telecom infrastructure, healthcare systems, and public health policies.
